Effects of Guanidinoethane Sulfonate and Taurine on Electroshock Seizures in Mice
Guanidinoethane sulfonate is a compound which has been recently found to inhibit competitively taurine uptake and thereby decrease the concentration of this amino acid in various organs including the brain in rats1 and mice2,3. Taurine, or 2-aminoethane sulfonate, is an inhibitory amino acid like γ-aminobutyric acid (GABA), glycine or β-alanine in the central nervous system (CNS) and is known to possess antiepileptic properties against various types of experimentally-induced seizures in mammals (for review see Barbeau and Huxtable4, Huxtable5, Durelli and Mutani6). Interference with GABA or glycine system in the CNS by specific receptor blockers such as bicuculline or strychnine causes convulsions7. Decreased GABA content of the brain caused by inhibiting glutamic acid decarboxylase activity also produces convulsions.In this study we investigate whether a selective decrease in the taurine concentration in the brain produced by guanidinoethane sulfonate can increase the susceptibility to electroshock seizures or modify the anticonvulsive action of phenobarbital or phenytoin against maximal electroshock seizures in mice.
KeywordsSulfur Amino Acid Maximal Electroshock Seizure Taurine Concentration Taurine Content Taurine Uptake
Unable to display preview. Download preview PDF.
- 3.M. Hiramatsu, H. Niiya and A. Mori, Effects of taurocyamine on taurine and other amino acid in brain, liver and muscle, Sulfur Amino Acids, 4: 227 (1981).Google Scholar
- 4.A. Barbeau and R. J. Huxtable, “Taurine and Neurological Disorders”, Raven Press, New York (1978).Google Scholar
- 5.R. J. Huxtable, Insights on function: metabolism and pharmacology of taurine in the brain, in:“The Role of Peptides and Amino Acids as Neurotransmitters,” J. B. Lombardini and A. D. Kenny, eds., Alan R. Liss, Inc., New York (1981).Google Scholar
- 7.D. M. Woodbury, Convulsant drugs: mechanisms of action, in: “Antiepileptic Drugs: Mechanisms of Action,” G. H. Glaser,J. K. Penry and D. M. Woodbury, eds., Raven Press, New York (1980).Google Scholar
- M. H. Thursby and A. H. Nevis, Anticonvulsant activity of taurine in electrically and osmotically induced seizures in mice and rats, Fed. Proc., 33:1494 (1974).Google Scholar
- 10.R. Oishi, N. Suenaga, T. Hidaka and T. Fukuda, Inhibitory effect of intraspinal injection of 6-hydroxydopamine on the clonic convulsion in maximal electroshock seizure, Brain Res., 169: 189 (1979).Google Scholar
- 11.E. A. Swinyard, Electrically induced convulsions, in:“Experimental Models of Epilepsy,” D.P. Purpura, J. K. Penry,D. Tower, D. M. Woodbury and R. Walter, eds., Raven Press, New York (1972).Google Scholar
- 14.K. Izumi, H. Igisu and T. Fukuda, Effects of edetate on seizure suppressing actions of taurine and GABA, Brain Res., 88: 576 (1975).Google Scholar
- 15.H. Iwata, T. Yamamoto, Y. Kumagae and A. Baba, Further study on cysteine sulfinate-induced EEG seizures in rats, in: “Sulfur Amino Acids: Biochemical and Clinical Aspects,”K. Kuriyama, R. J. Huxtable and H. Iwata, eds., Alan R. Liss, Inc., New York (1983).Google Scholar
- 16.S. I. Baskin and C. M. Finney, Factors that modify the tissue concentration or metabolism of taurine, in:“The Effects of Taurine on Excitable Tissues,” S. W. Schaffer,S. I. Baskin and J. J. Kocsis, eds., MTP Press, Lancaster (1981).Google Scholar